GCP
MED icon

Gill Capital Partners’s Medifast MED Stock Holding History

Gill Capital Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1K Buy
+108
New +$1.16K ﹤0.01% 592

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Gill Capital Partners's MED Position: Q1 2026 in Review

Gill Capital Partners opened a new position in Medifast (MED) in Q1 2026: 108 shares worth $1.1K. The stake represents ﹤0.01% of the portfolio and ranks #592 among its holdings.

111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • Gill Capital Partners held 108 shares of Medifast worth $1.1K as of Q1 2026.
  • Medifast was a new Gill Capital Partners position in Q1 2026.
  • Medifast made up ﹤0.01% of Gill Capital Partners's portfolio in Q1 2026, its #592 holding.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Gill Capital Partners's 13F filing for Q1 2026, filed 13 Apr 2026.